Biomarker study of ARB-1598 in chronically infected HBV patients
Phase of Trial: Phase II
Latest Information Update: 09 Mar 2016
At a glance
- Drugs CMP 001 (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Arbutus Biopharma
- 09 Mar 2016 According to an Arbutus Biopharma media release,the company is planning to initiate in the second half of 2016.
- 13 Jan 2016 New trial record
- 10 Jan 2016 According to Arbutus media release, company is planning to initiate this trial in 2016.